Loading
Latest filing published 15 Dec 2025 for Jaguar Health, Inc..
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
This profile gathers the share dealings of Carol R. Lizak in Jaguar Health, Inc., where the filings describe the role as finance chief. Between 13 September 2021 and 11 December 2025, the trades on record add up to 9 filings.
Purchases make up the whole of the open-market record (1 purchase, €17k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 3 share grants and 5 option exercises.
The latest filing, published on 15 December 2025, reports a share grant in Jaguar Health, Inc. The last purchase on record was published on 30 March 2022, which is 1,669 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations